BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32135169)

  • 1. HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential.
    He S; Moutaoufik MT; Islam S; Persad A; Wu A; Aly KA; Fonge H; Babu M; Cayabyab FS
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188355. PubMed ID: 32135169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of protein quality control of the human ether-à-go-go related gene K
    Ledford HA; Ren L; Thai PN; Park S; Timofeyev V; Sirish P; Xu W; Emigh AM; Priest JR; Perez MV; Ashley EA; Yarov-Yarovoy V; Yamoah EN; Zhang XD; Chiamvimonvat N
    Heart Rhythm; 2022 Feb; 19(2):281-292. PubMed ID: 34634443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional impact of hERG: from physiological role to target of anticancer therapy].
    Šatková J; Bébarová M
    Vnitr Lek; 2017; 63(2):114-123. PubMed ID: 28334543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoids and hERG channels: Friends or foes?
    Saponara S; Fusi F; Iovinelli D; Ahmed A; Trezza A; Spiga O; Sgaragli G; Valoti M
    Eur J Pharmacol; 2021 May; 899():174030. PubMed ID: 33727059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid roles in hERG function and interactions with drugs.
    Kudaibergenova M; Perissinotti LL; Noskov SY
    Neurosci Lett; 2019 May; 700():70-77. PubMed ID: 29758301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia reduces mature hERG channels through calpain up-regulation.
    Lamothe SM; Song W; Guo J; Li W; Yang T; Baranchuk A; Graham CH; Zhang S
    FASEB J; 2017 Nov; 31(11):5068-5077. PubMed ID: 28784631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.
    Rajamani S; Eckhardt LL; Valdivia CR; Klemens CA; Gillman BM; Anderson CL; Holzem KM; Delisle BP; Anson BD; Makielski JC; January CT
    Br J Pharmacol; 2006 Nov; 149(5):481-9. PubMed ID: 16967046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression.
    Szendrey J; Lamothe SM; Vanner S; Guo J; Yang T; Li W; Davis J; Joneja M; Baranchuk A; Zhang S
    Cardiovasc Res; 2019 Aug; 115(10):1500-1511. PubMed ID: 30544220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The S1 helix critically regulates the finely tuned gating of Kv11.1 channels.
    Phan K; Ng CA; David E; Shishmarev D; Kuchel PW; Vandenberg JI; Perry MD
    J Biol Chem; 2017 May; 292(18):7688-7705. PubMed ID: 28280240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM Structure of the Open Human Ether-à-go-go-Related K
    Wang W; MacKinnon R
    Cell; 2017 Apr; 169(3):422-430.e10. PubMed ID: 28431243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM Structure of K
    Asai T; Adachi N; Moriya T; Oki H; Maru T; Kawasaki M; Suzuki K; Chen S; Ishii R; Yonemori K; Igaki S; Yasuda S; Ogasawara S; Senda T; Murata T
    Structure; 2021 Mar; 29(3):203-212.e4. PubMed ID: 33450182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the Cyclic Nucleotide-Binding Homology Domain of the hERG Channel and Its Insight into Type 2 Long QT Syndrome.
    Li Y; Ng HQ; Li Q; Kang C
    Sci Rep; 2016 Mar; 6():23712. PubMed ID: 27025590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrameric Assembly of K
    Li K; Jiang Q; Bai X; Yang YF; Ruan MY; Cai SQ
    Mol Cell; 2017 Jan; 65(1):52-65. PubMed ID: 27916661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSSF-hERG: A machine-learning-based hERG potassium channel-specific scoring function for chemical cardiotoxicity prediction.
    Meng J; Zhang L; Wang L; Li S; Xie D; Zhang Y; Liu H
    Toxicology; 2021 Dec; 464():153018. PubMed ID: 34757159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Ether-a-go-go-related Gene (hERG) Potassium Channel Represents an Unusual Target for Protease-mediated Damage.
    Lamothe SM; Guo J; Li W; Yang T; Zhang S
    J Biol Chem; 2016 Sep; 291(39):20387-401. PubMed ID: 27502273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
    Thomas D; Karle CA; Kiehn J
    Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant.
    Al-Moubarak E; Shiels HA; Zhang Y; Du C; Hanington O; Harmer SC; Dempsey CE; Hancox JC
    Cell Mol Life Sci; 2021 Dec; 78(23):7899-7914. PubMed ID: 34727194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.